British Columbia is at a critical juncture in addressing the opioid crisis. It is the second leading province in opioid poisoning-related hospitalizations, with the B.C. Emergency Health Services paramedics responding to 40,543 poisonings in 2024 – an average of 111 calls a day. These figures underscore the need for comprehensive solutions including access to opioid overdose reversal medications, prevention programs, treatment and community based services.
Central to combating this epidemic is naloxone – a medication that can help reverse the effects of an opioid poisoning when administered promptly. It comes in two forms: intramuscular (injectable) and intranasal (naloxone nasal spray).
Currently, intramuscular naloxone is available at no cost through the B.C. Centre for Disease Control (BCCDC) Take Home Naloxone program. In 2024 alone, 501,138 kits were shipped to sites through the program, which demonstrates the widespread need for this life-saving intervention.
"Education and preparedness are key in addressing the opioid crisis," says Paul Williams, senior vice president, products business and president of Emergent Canada. "Ensuring broader access to life-saving medications like naloxone will also empower and equip bystanders to respond promptly when minutes matter. Intranasal naloxone's ease of use makes it ideal for rapid deployment in emergencies, enabling individuals to act swiftly.”
Emergent BioSolutions is at the forefront of the battle against the opioid poisoning crisis. With over 25 years of experience delivering protecting and lifesaving solutions to communities around the world, Emergent’s product portfolio includes NARCAN® Nasal Spray, a naloxone nasal spray indicated for emergency use to reverse known or suspected opioid overdose until medical help arrives.
The opioid crisis has impacted people from all walks of life. In B.C., youth face a grim reality where illicit drug toxicity has overtaken motor vehicle accidents as the leading cause of death for those aged 10 to 18. Moreover, trade workers, often the backbone of the community, represented over half of illicit drug fatalities among individuals who were employed at the time of their death from 2017 to 2021.
The scope of the opioid crisis is increasing calls for comprehensive solutions to help reduce opioid poisoning deaths. Work to expand access to naloxone nasal spray was a commitment outlined in the recent mandate letter to B.C.’s Minister of Health, Honourable Josie Osborne.
"We understand that increasing public awareness and access to naloxone can empower more individuals to respond to opioid poisoning emergencies," Williams says. "This is why we’re making a concerted effort, alongside governments, nonprofits and associations, to educate the public about the benefits of having naloxone nasal spray available in the community for anyone who needs it.”